High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study

More effective therapeutic strategies are required for patients with poor-prognosis systemic sclerosis (SSc). A phase 2 single-arm study of high-dose immunosuppressive therapy (HDIT) and autologous CD34-selected hematopoietic cell transplantation (HCT) was conducted in 34 patients with diffuse cutan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nash, Richard A., McSweeney, Peter A., Crofford, Leslie J., Abidi, Muneer, Chen, Chien-Shing, Godwin, J. David, Gooley, Theodore A., Holmberg, Leona, Henstorf, Gretchen, LeMaistre, C. Fred, Mayes, Maureen D., McDonagh, Kevin T., McLaughlin, Bernadette, Molitor, Jerry A., Nelson, J. Lee, Shulman, Howard, Storb, Rainer, Viganego, Federico, Wener, Mark H., Seibold, James R., Sullivan, Keith M., Furst, Daniel E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2007
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1939909/
https://ncbi.nlm.nih.gov/pubmed/17452515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-02-072389
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados